MID Labs was founded by Dr. Carl Wang in 1981 and has been associated with vitreoretinal surgery from its infancy. Not only has MID Labs invented the tools for modern vitrectomy, but as a company, we have been instrumental in revolutionizing the ophthalmic field through our products. MID Labs continues to innovate with the MID Labs branded product line which is supplied to more than 30 countries around the world. These products set the standard for precision, performance, and quality. Our Mission: "To excel at providing quality and innovative ophthalmic products that benefit patients around the world."​

THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots. THINK Surgical robots are open platforms providing support for implant brands from multiple manufacturers, enabling the choice of implant to be driven by the surgeon.

Aerin’s mission is to provide Ear, Nose, and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal airway conditions. The company’s FDA-cleared products, VivAer® for nasal airway obstruction and RhinAer® for chronic rhinitis, leverage Aerin’s proprietary, temperature-controlled technology, which allows ENT physicians to reliably improve patients’ symptoms with an in-office procedure performed with local anesthetic. For more information, please visit www.aerinmedical.com. Full Social Media Terms of Use are available at aerinmedical.com/social-terms-of-use

Xandex Inc. develops products and offers services to worldwide customer bases in the solar energy and semiconductor equipment markets. Our Solar and Semiconductor divisions service customers in their respective markets throughout North America, Asia and the EU. Xandex also invests in promising technology ventures through our investments arm, Xandex Investments LLC.

Stellartech Research Corporation designs, develops and manufactures an array of innovative diagnostic and therapeutic devices for a wide range of medical device companies. These “smart” medical devices incorporate cutting edge technology—such as complex electronics for sensor feedback and control and “synergistic” features to facilitate market adoption. Stellartech excels at “system optimization”, integrating an energy generator with a percutaneous catheter or probe to optimize the delivery of therapeutic energy. With experience in many energy modalities and deep expertise in the interaction of energy with tissue, Stellartech has helped its partners meet some of the most difficult clinical challenges in therapeutic energy delivery. Stellartech’s comprehensive in-house engineering and manufacturing capabilities are supported by a tightly controlled, up to date quality system. With deep technical expertise and a commitment to optimal clinical performance, Stellartech delivers medical systems that advance the practice of medicine

cPacket Networks de-risks IT I&O through network-aware service and security assurance across hybrid and multi-cloud environments. Our AIOps-ready Intelligent Observability Platform provides single-pane-of-glass analytics and provides the deep network visibility required for today’s complex IT environments. The result: increased service agility, enhanced experience assurance, and faster transactional velocity. Learn more at www.cpacket.com

RKI Instruments, Inc. is an innovative gas detection company located in Union City, California. RKI was established in 1994 by Sandra Gallagher and myself. We both believe that customers and distributors deserve a reliable source for advanced gas detection equipment as well as solutions to specific gas monitoring applications. RKI is partnered with Riken Keiki Co. Ltd., the world leader in gas detection and sensor technologies. In business for over 70 years, Riken has sold over 800,000 portable and fixed gas monitors worldwide with annual sales exceeding $220 million. They have over 700 employees, a large number of which are engineers and scientists. RKI is the exclusive North American supplier of Riken products. Every year, RKI has continued to achieve a high level of growth which is attributed to our sales and support of Riken products and the ability to develop our own line of products around Riken’s long lasting sensors. This capability of sales, support, and development is made possible by our seasoned professionals. Each RKI employee has an average of 12 years of gas detection experience, and the top 6 executives combined industry experience totals over 140 years. This combination of quality products and knowledgeable supportive people provides you with the ability and opportunity to confidently face almost any gas monitoring application, with equipment built to last. When you call RKI, you will get solutions and answers to your gas detection needs. RKI provides Gas Detection for Life. Not only will our equipment protect your life and property from the hazards of gases and vapors, but with proper care, it may also be the last gas detector you will ever need to purchase.

Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Since 2005, the company has continually sought to improve the treatment of vascular disease with: - Drug-eluting coronary stent systems (DES) - Fully resorbable drug-eluting scaffold systems (BRS) - Drug-eluting coronary bioadaptor systems Its latest innovation — the DynamX™ Coronary Bioadaptor System — is designed to be a significant advancement beyond drug-eluting stents (DES). Elixir Medical’s innovations are designed to make a meaningful change in patients’ lives. The company does not simply want to engineer a better medical device. Saving lives and helping patients enjoy their daily life is what drives us every day.

Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care. Ceribell’s mission is to make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions. The Ceribell system provides rapid access to accurate diagnostic information and continuous monitoring at the bedside 24/7, enabling precise patient care and hospital-wide efficiencies. The Ceribell system first received FDA 510(k) clearance in 2017 and is commercially available in the United States. The latest ClarityPro™ AI algorithm is the first and only FDA-indicated software for the diagnosis of Electrographic Status Epilepticus with U.S. Centers for Medicare and Medicaid Services approved New Technology Add-on Payment (NTAP).

Neptune Medical is a venture capital funded medical device start-up, located in the Silicon Valley town of Burlingame. We develop, manufacture, and commercialize high-volume, high clinical utility medical devices initially commercialized for gastroenterology, see our website below. Our patent-pending technology is foundational and will have a broad impact across multiple additional clinical areas, including including GI, cardiovascular, pulmonary, and neuro. Our Triton Medical Robotics division is developing flexible robotic systems that address enormous unmet needs across multiple major medical indications. Our products incorporate unique Dynamic Rigidization™ technology that instantly toggles thin-walled tubes- such as overtubes, catheters or cannulae - between flexible and rigid states. This novel technology creates unprecedented opportunities for significantly enhanced access and control deep within the body. Neptune Medical currently has ~50 full time employees across all divisions, including a core team of serially successful medical device entrepreneurs. The company has raised over $30M in capital from a diversified investor base, including venture capital, private equity, and industry insider and clinician angel investors.

Earlens Corporation is a privately held medical device company committed to providing hearing impaired patients with a state-of-art hearing solution that is designed to change the current standard of care for sound performance.